Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: The past, the present, and the future

被引：34
作者：
Bangsberg, David R. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
AIDS AND BEHAVIOR | 2006年 / 10卷 / 03期
关键词：
HIV; adherence; resistance; electronic medication monitor; CASI; mediset; pill box organizer;
D O I：
10.1007/s10461-006-9121-7
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：249 / 251
页数：3
相关论文
共 22 条
[1]   Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure [J].
Artinian, NT ;
Harden, JK ;
Kronenberg, MW ;
Vander Wal, JS ;
Daher, E ;
Stephens, Q ;
Bazzi, RI .
HEART & LUNG, 2003, 32 (04) :226-233
[2]   Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness [J].
Bangsberg, DR ;
Acosta, EP ;
Gupta, R ;
Guzman, D ;
Riley, ED ;
Harrigan, PR ;
Parkin, N ;
Deeks, SG .
AIDS, 2006, 20 (02) :223-231
[3]   Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice [J].
Bangsberg, DR ;
Bronstone, A ;
Chesney, MA ;
Hecht, FM .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S107-S111
[4]   High levels of adherence do not prevent accumulation of HIV drug resistance mutations [J].
Bangsberg, DR ;
Charlebois, ED ;
Grant, RM ;
Holodniy, M ;
Deeks, SG ;
Perry, S ;
Conroy, KN ;
Clark, R ;
Guzman, D ;
Zolopa, A ;
Moss, A .
AIDS, 2003, 17 (13) :1925-1932
[5]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[6]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[7]  
Bangsberg DR, 2001, J ACQ IMMUN DEF SYND, V26, P435, DOI 10.1097/00126334-200104150-00005
[8]   Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations [J].
Bova, CA ;
Fennie, KP ;
Knafl, GJ ;
Dieckhaus, KD ;
Watrous, E ;
Williams, AB .
AIDS AND BEHAVIOR, 2005, 9 (01) :103-110
[9]  
de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014
[10]   Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy [J].
Gross, R ;
Bilker, WB ;
Friedman, HM ;
Coyne, JC ;
Strom, BL .
AIDS, 2002, 16 (13) :1835-1837
123